HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC sunscreens

This article was originally published in The Rose Sheet

Executive Summary

FDA is requesting safety and effectiveness data on diethylhexyl butamido triazone up to 3% as a single active ingredient and in combination with other active ingredients in sunscreens, agency announces in July 26 Federal Register 1notice. FDA determined a time and extent application for the ingredient, submitted by 3V Sept. 16, 2005, was eligible for inclusion in the OTC sunscreen monograph; however, the agency notes, the TEA did not include an official or proposed U.S. Pharmacopeia-National Formulary drug monograph, and the firm should submit that information as part of the safety and effectiveness data...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS014111

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel